Ignite Creation Date:
2024-05-06 @ 1:30 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04042558
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2019-07-29
Brief Title:
A Study Evaluating Platinum-Pemetrexed-Atezolizumab -Bevacizumab for Patients With Stage IIIBIV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
Sponsor:
Centre Francois Baclesse
Organization:
Centre Francois Baclesse
Organization Data
Organization:
Centre Francois Baclesse
Class:
OTHER
Study ID:
GFPC 06-2018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Francois Baclesse
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GFPC | UNKNOWN |